HIV-1 remission following CCR5Δ32/Δ32 haematopoietic stem-cell transplantation RK Gupta, S Abdul-Jawad, LE McCoy, HP Mok, D Peppa, M Salgado, ... Nature 568 (7751), 244-248, 2019 | 722 | 2019 |
Simultaneous detection of influenza viruses A and B using real-time quantitative PCR LJR Van Elden, M Nijhuis, P Schipper, R Schuurman, AM Van Loon Journal of clinical microbiology 39 (1), 196-200, 2001 | 638 | 2001 |
Rapid changes in human immunodeficiency virus type 1 RNA load and appearance of drug-resistant virus populations in persons treated with lamivudine (3TC) R Schuurman, M Nijhuis, R Van Leeuwen, P Schipper, D De Jong, ... Journal of Infectious Diseases 171 (6), 1411-1419, 1995 | 607 | 1995 |
Fifteen years of HIV Protease Inhibitors: raising the barrier to resistance AMJ Wensing, NM van Maarseveen, M Nijhuis Antiviral research 85 (1), 59-74, 2010 | 530 | 2010 |
Reduced replication of 3TC‐resistant HIV‐1 variants in primary cells due to a processivity defect of the reverse transcriptase enzyme. NK Back, M Nijhuis, W Keulen, CA Boucher, BO Oude Essink, ... The EMBO journal 15 (15), 4040-4049, 1996 | 503 | 1996 |
International AIDS Society global scientific strategy: towards an HIV cure 2016 SG Deeks, SR Lewin, AL Ross, J Ananworanich, M Benkirane, P Cannon, ... Nature medicine 22 (8), 839-850, 2016 | 494 | 2016 |
Increased fitness of drug resistant HIV-1 protease as a result of acquisition of compensatory mutations during suboptimal therapy M Nijhuis, R Schuurman, D De Jong, J Erickson, E Gustchina, J Albert, ... Aids 13 (17), 2349-2359, 1999 | 473 | 1999 |
IL-10 is an important mediator of the enhanced susceptibility to pneumococcal pneumonia after influenza infection KF van der Sluijs, LJR van Elden, M Nijhuis, R Schuurman, JM Pater, ... The Journal of Immunology 172 (12), 7603-7609, 2004 | 434 | 2004 |
CRISPR/Cas9-mediated genome editing of herpesviruses limits productive and latent infections FR van Diemen, EM Kruse, MJG Hooykaas, CE Bruggeling, AC Schürch, ... PLoS pathogens 12 (6), e1005701, 2016 | 335 | 2016 |
Microdomains of the C-type lectin DC-SIGN are portals for virus entry into dendritic cells A Cambi, F De Lange, NM Van Maarseveen, M Nijhuis, B Joosten, ... The Journal of cell biology 164 (1), 145-155, 2004 | 286 | 2004 |
Frequent detection of human coronaviruses in clinical specimens from patients with respiratory tract infection by use of a novel real-time reverse-transcriptase polymerase … LJR van Elden, AM Anton M, F van Alphen, KAW Hendriksen, ... The Journal of infectious diseases 189 (4), 652-657, 2004 | 266 | 2004 |
Evidence for HIV-1 cure after CCR5Δ32/Δ32 allogeneic haemopoietic stem-cell transplantation 30 months post analytical treatment interruption: a case report RK Gupta, D Peppa, AL Hill, C Gálvez, M Salgado, M Pace, LE McCoy, ... The Lancet HIV 7 (5), e340-e347, 2020 | 248 | 2020 |
Implications of antiretroviral resistance on viral fitness M Nijhuis, S Deeks, C Boucher Current opinion in infectious diseases 14 (1), 23-28, 2001 | 247 | 2001 |
A novel substrate-based HIV-1 protease inhibitor drug resistance mechanism M Nijhuis, NM Van Maarseveen, S Lastere, P Schipper, E Coakley, ... PLoS medicine 4 (1), e36, 2007 | 217 | 2007 |
Polymerase chain reaction is more sensitive than viral culture and antigen testing for the detection of respiratory viruses in adults with hematological cancer and pneumonia LJR Elden, MGJ Kraaij, M Nijhuis, KAW Hendriksen, AW Dekker, ... Clinical infectious diseases 34 (2), 177-183, 2002 | 213 | 2002 |
Evolution of lamivudine resistance in human immunodeficiency virus type 1-infected individuals: the relative roles of drift and selection SDW Frost, M Nijhuis, R Schuurman, CAB Boucher, AJL Brown Journal of virology 74 (14), 6262-6268, 2000 | 212 | 2000 |
HIV monotherapy with ritonavir-boosted protease inhibitors: a systematic review WFW Bierman, MA van Agtmael, M Nijhuis, SA Danner, CAB Boucher Aids 23 (3), 279-291, 2009 | 205 | 2009 |
Rapid and Sensitive Routine Detection of All Members of the Genus Enterovirus in Different Clinical Specimens by Real-Time PCR M Nijhuis, N van Maarseveen, R Schuurman, S Verkuijlen, M de Vos, ... Journal of Clinical Microbiology 40 (10), 3666-3670, 2002 | 205 | 2002 |
Stochastic processes strongly influence HIV-1 evolution during suboptimal protease-inhibitor therapy M Nijhuis, CAB Boucher, P Schipper, T Leitner, R Schuurman, J Albert Proceedings of the National Academy of Sciences 95 (24), 14441-14446, 1998 | 189 | 1998 |
Human Immunodeficiency Virus Gag and protease: partners in resistance A Fun, AMJ Wensing, J Verheyen, M Nijhuis Retrovirology 9, 1-14, 2012 | 183 | 2012 |